SCHEMBL2997849

SCHEMBL2997849

Cc1ccc2oc(-c3ccc(CCl)cc3)nc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 11/20 0.74
KDM4E B2RXH2 11/20 0.74
ALDH1A1 P00352 11/20 0.74
RAB9A P51151 11/20 0.74
HPGD P15428 10/20 0.74
NPC1 O15118 10/20 0.74
HSD17B10 Q99714 9/20 0.74
TP53 P04637 8/20 0.74
CASP3 P42574 4/20 0.66
SENP7 Q9BQF6 4/20 0.66
SENP6 Q9GZR1 4/20 0.66
SENP8 Q96LD8 3/20 0.66
POLB P06746 1/20 0.66
NFKB1 P19838 6/20 0.62
NFKB2 Q00653 6/20 0.62
RELA Q04206 6/20 0.62
LMNA P02545 1/20 0.62
MMP2 P08253 1/20 0.59
MMP9 P14780 1/20 0.59
MMP8 P22894 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14947173 0.87 ALDH1A1 (0.96) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL3288386 0.86 ALDH1A1 (1.00) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL15047797 0.86 ALDH1A1 (0.93) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL19380025 0.85 SMN1; SMN2 (0.74) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL11642093 0.85 SMN1; SMN2 (0.74) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL1736234 0.84 KDM4E (0.68) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL10218249 0.83 SMN1; SMN2 (0.82) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL17122218 0.82 SMN1; SMN2 (0.68) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL10045311 0.81 ALDH1A1 (0.84) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD
SCHEMBL10061932 0.80 SMN1; SMN2 (0.81) SMN1; SMN2KDM4EALDH1A1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118666902-A Benzoxazole fluorescent whitening agent and preparation method thereof 江苏格罗瑞化学有限公司 2024-09-20 CN claimed
CN-118666902-A Benzoxazole fluorescent whitening agent and preparation method thereof 江苏格罗瑞化学有限公司 2024-09-20 CN disclosed
US-10053428-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-08-21 US disclosed
US-20170260139-A1 NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-14 US disclosed
US-20170260139-A1 NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-14 US disclosed
US-20170260139-A1 NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-14 US disclosed
US-9688636-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-27 US disclosed
US-9688636-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-27 US disclosed
US-9688636-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-27 US disclosed
EP-2875003-B1 NEW 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS UND THEIR USE Bayer Pharma AG (DE) 2016-11-16 EP disclosed
US-20140031391-A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-01-30 US disclosed
CN-101177539-B Hemicyanine dyes containing coumarin Huaihai Technical College 2010-10-27 CN disclosed
US-7781470-B2 Aminodicarboxylic acid derivatives having pharmaceutical properties BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-24 US disclosed
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 US disclosed
US-20090203906-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES BAYER AKTIENGESELLSCHAFT (DE) 2009-08-13 US disclosed
US-7517896-B2 Aminodicarboxylic acid derivatives having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2009-04-14 US disclosed
CN-101177539-A Hemicyanine dyes containing coumarin HUAIHAI TECHNICAL COLLEGE ZHAN (CN) 2008-05-14 CN disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 US disclosed
US-7087644-B1 Derivatives of dicarboxylic acid having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 US disclosed
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031391-A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use TNNT2, TNNI3, FABP3 SMN1; SMN2 3433/4885KDM4E 3868/4885ALDH1A1 679/4885
US-20090203906-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES DDC, AADAT, PTGIS SMN1; SMN2 3924/4885KDM4E 244/4885ALDH1A1 214/4885
US-10053428-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use TNNT2, TNNI3, FABP3 SMN1; SMN2 3139/4885KDM4E 3842/4885ALDH1A1 684/4885
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties PC, GOT2, SDHA SMN1; SMN2 3741/4885KDM4E 3141/4885ALDH1A1 302/4885
US-20170260139-A1 NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE TNNT2, TNNI3, FABP3 SMN1; SMN2 3433/4885KDM4E 3868/4885ALDH1A1 679/4885
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties DDC, AADAT, PTGIS SMN1; SMN2 3924/4885KDM4E 244/4885ALDH1A1 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.